KA/EN
Register
Medicines reference
Search
Search
Product

Dogferon

Favourites

Canine interferon alpha · Bioinvest STC Ltd

1 form: solution. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Enter weight; the matching row will be highlighted.
Form Species Weight Dose Frequency Georgia
1000000 IU/ml injection, Solution · Dog up to 10 kg Dog up to 10 kg 1 ml
For treatment of canine parvovirus infection; begin at the first signs when possible. Contraindicated with interferon hypersensitivity, severe hepatic lesions, hypochromic anaemia, autoimmune disease, pregnancy or lactation. Do not mix in the same syringe with another medicine. If an allergic reaction occurs, discontinue and provide antihistamine and symptomatic therapy.
 · once daily for 5-7 days		 once daily for 5-7 days Georgia Yes, veterinary
In force until 16 Jul 2031
Veterinary (National Food Agency)
In the register: დოგფერონი®
№ 001222
Verified on: 21 Oct 2026
1000000 IU/ml injection, Solution · Dog over 10 kg Dog over 10 kg 0.1 ml/kg
For treatment of canine parvovirus infection; begin at the first signs when possible. Contraindicated with interferon hypersensitivity, severe hepatic lesions, hypochromic anaemia, autoimmune disease, pregnancy or lactation. Do not mix in the same syringe with another medicine. If an allergic reaction occurs, discontinue and provide antihistamine and symptomatic therapy.
 · once daily for 5-7 days		 once daily for 5-7 days Georgia Yes, veterinary
In force until 16 Jul 2031
Veterinary (National Food Agency)
In the register: დოგფერონი®
№ 001222
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Dogferon 1000000 IU/ml injection, Solution

5 x 2.5 ml for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
5.4/10
Weak evidence support
vetman assessment

Dogferon

1000000 IU/ml injection, 5 x 2.5 ml for dogs
Assessed clinical scopeDog · Confirmed canine parvoviral enteritis, as an adjunct to standard intensive supportive treatment · Intramuscular
Care settingInpatient or closely supervised veterinary care
vetman score 5.4/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 001222 · Verified on 21 Oct 2026

The exact product has a small controlled evidence base, but the available studies are too limited and insufficiently independently replicated for a strong recommendation.

Regulatory and scientific credibility4.5/10

The exact presentation is registered in Georgia and has a regulator-approved instruction, but the public dossier and international regulatory assessment are limited.

Clinical efficacy5.5/10

A small blinded placebo-controlled exact-product study reported faster recovery and better outcomes, supported by a second small publication; large independent replication is absent.

Safety and tolerability5.5/10

Small studies and the instruction show no clear serious toxicity signal at the labelled dose, but independent pharmacovigilance evidence is limited.

Clinical practicality6.5/10

Once-daily IM dosing for 5-7 days is practical for the usual hospitalised or closely supervised parvovirus patient and does not itself represent a major treatment burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Contraindicated in severe hepatic lesions, hypochromic anaemia, autoimmune disease, pregnancy or lactation.
  • Do not mix with another medicine in the same syringe.
  • It is an adjunct and does not replace fluid therapy, electrolyte correction, antiemetic care and other essential intensive treatment.
Assessment sources
  1. Bioinvest Dogferon2021
  2. Dogferon parvovirus trial 20212021
  3. Dogferon study 20222022
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Canine interferon alpha1000000 IU/ml
Formulation Type
Solution
Administration route
Intramuscular
Manufacturer
Bioinvest STC Ltd · Russia
Manufacturer (register)
Scientific Technological Center Bioinvest Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1826, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 16 Jul 2031
Veterinary (National Food Agency)
In the register: დოგფერონი®
№ 001222
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1 ml
For treatment of canine parvovirus infection; begin at the first signs when possible. Contraindicated with interferon hypersensitivity, severe hepatic lesions, hypochromic anaemia, autoimmune disease, pregnancy or lactation. Do not mix in the same syringe with another medicine. If an allergic reaction occurs, discontinue and provide antihistamine and symptomatic therapy.
 Dog up to 10 kg Intramuscular once daily for 5-7 days
Bioinvest Dogferon
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Dogferon solution for injection - Rosselkhoznadzor-approved instruction
Official veterinary product instruction, 2021
0.1 ml/kg
For treatment of canine parvovirus infection; begin at the first signs when possible. Contraindicated with interferon hypersensitivity, severe hepatic lesions, hypochromic anaemia, autoimmune disease, pregnancy or lactation. Do not mix in the same syringe with another medicine. If an allergic reaction occurs, discontinue and provide antihistamine and symptomatic therapy.
 Dog over 10 kg Intramuscular once daily for 5-7 days
Bioinvest Dogferon
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Dogferon solution for injection - Rosselkhoznadzor-approved instruction
Official veterinary product instruction, 2021

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 21 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗